{"Q": 1, "answer": "no", "rationale": "The segment reports financial information but does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_10564", "batch_size": 200, "batch_pos": 130, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment describes stock market movement ('climbed') which is a background economic condition, not the threat's direct impact.", "method": "llm_batch", "batch_id": "batch_2_18560", "batch_size": 200, "batch_pos": 102, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment discusses financial metrics, which are excluded from Q3.", "method": "llm_batch", "batch_id": "batch_3_2808", "batch_size": 200, "batch_pos": 81, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_18348", "batch_size": 200, "batch_pos": 76, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports stock performance and potential deal but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_16280", "batch_size": 200, "batch_pos": 73, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser with scale contrast.", "method": "llm_batch", "batch_id": "batch_6_9812", "batch_size": 200, "batch_pos": 55, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "No bare negation found.", "method": "llm_batch", "batch_id": "batch_7_4596", "batch_size": 200, "batch_pos": 47, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Reports stock climb after report of funding deal ('U.S. government is near a deal to fund a late-stage trial') which is a capability/action without explicit calming.", "method": "llm_batch", "batch_id": "batch_8_1968", "batch_size": 200, "batch_pos": 163, "statement_text": "Moderna shares climbed 2.4% premarket on Thursday after a report that the U.S. government is near a deal to fund a late-stage trial of the drugmaker's experimental mRNA bird-flu vaccine.", "article_id": 1648}
